Sequoia Financial Advisors LLC Decreases Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Sequoia Financial Advisors LLC lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 6.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,814 shares of the medical device company’s stock after selling 278 shares during the period. Sequoia Financial Advisors LLC’s holdings in Cooper Companies were worth $322,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. T. Rowe Price Investment Management Inc. boosted its holdings in Cooper Companies by 2.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company’s stock valued at $705,928,000 after acquiring an additional 155,233 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Cooper Companies by 1.5% in the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock valued at $460,066,000 after acquiring an additional 74,501 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Cooper Companies by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock valued at $449,907,000 after acquiring an additional 109,907 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Cooper Companies by 517.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company’s stock valued at $324,466,000 after acquiring an additional 2,957,421 shares in the last quarter. Finally, Norges Bank bought a new stake in Cooper Companies in the fourth quarter valued at $217,906,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the stock. Wells Fargo & Company dropped their target price on shares of Cooper Companies from $118.00 to $93.00 and set an “overweight” rating on the stock in a report on Friday, May 30th. Needham & Company LLC upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 target price on the stock in a report on Tuesday, June 17th. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Finally, UBS Group upgraded shares of Cooper Companies to a “buy” rating in a report on Tuesday, June 17th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $99.70.

Cooper Companies Trading Down 0.0%

Shares of NASDAQ COO opened at $73.01 on Friday. The firm’s 50 day moving average price is $75.78 and its 200-day moving average price is $83.48. The company has a market cap of $14.60 billion, a PE ratio of 35.44, a P/E/G ratio of 1.78 and a beta of 0.99. The Cooper Companies, Inc. has a 52-week low of $65.00 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.03. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.85 earnings per share. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.